These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21352159)

  • 1. Case reports: an opportunity for early intervention: velo-cardio-facial syndrome and psychosis.
    Starling J; Harris AW
    Early Interv Psychiatry; 2008 Nov; 2(4):262-7. PubMed ID: 21352159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
    Gothelf D; Schaer M; Eliez S
    Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age.
    Evers LJ; De Die-Smulders CE; Smeets EE; Clerkx MG; Curfs LM
    Genet Couns; 2009; 20(4):307-15. PubMed ID: 20162865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychiatric disorders in velo-cardio-facial syndrome].
    Maesen A; Claes SJ; Neyrinck K
    Tijdschr Psychiatr; 2010; 52(1):51-6. PubMed ID: 20054797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Velo-cardio-facial syndrome at the psychiatry consulting-liaison service in a general hospital].
    Fernández-Egea E; Ferrer del Alamo A; Torrebadell Burriel M; Carrió Ybáñez A
    Actas Esp Psiquiatr; 2006; 34(1):67-8. PubMed ID: 16525908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The facial phenotype of the velo-cardio-facial syndrome.
    Butts SC
    Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):343-50. PubMed ID: 19062108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Velo-cardio-facial syndrome: 30 Years of study.
    Shprintzen RJ
    Dev Disabil Res Rev; 2008; 14(1):3-10. PubMed ID: 18636631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encoding and retrieval processes in velo-cardio-facial syndrome (VCFS).
    Debbané M; Glaser B; Eliez S
    Neuropsychology; 2008 Mar; 22(2):226-34. PubMed ID: 18331165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR
    Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annotation: velo-cardio-facial syndrome.
    Murphy KC
    J Child Psychol Psychiatry; 2005 Jun; 46(6):563-71. PubMed ID: 15877762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q 11.2 deletion syndrome.
    Dufour F; Schaer M; Debbané M; Farhoumand R; Glaser B; Eliez S
    Neuropsychologia; 2008 Oct; 46(12):2986-92. PubMed ID: 18616958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study.
    Campbell LE; Daly E; Toal F; Stevens A; Azuma R; Catani M; Ng V; van Amelsvoort T; Chitnis X; Cutter W; Murphy DG; Murphy KC
    Brain; 2006 May; 129(Pt 5):1218-28. PubMed ID: 16569671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Velo-cardio-facial syndrome: a review of 120 patients.
    Goldberg R; Motzkin B; Marion R; Scambler PJ; Shprintzen RJ
    Am J Med Genet; 1993 Feb; 45(3):313-9. PubMed ID: 8434617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catatonia in an adolescent with velo-cardio-facial syndrome.
    Faedda GL; Wachtel LE; Higgins AM; Shprintzen RJ
    Am J Med Genet A; 2015 Sep; 167A(9):2150-3. PubMed ID: 25832449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine treatment of psychosis associated with velo-cardio-facial syndrome: benefits and risks.
    Gladston S; Clarke DJ
    J Intellect Disabil Res; 2005 Jul; 49(Pt 7):567-70. PubMed ID: 15966965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prader-Willi psychiatric syndrome and Velo-Cardio-Facial psychiatric syndrome.
    Verhoeven WM; Tuinier S; Curfs LM
    Genet Couns; 2000; 11(3):205-13. PubMed ID: 11043428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High risk for psychosis in velo-cardio-facial sydnrome. Description of symptoms and a case report].
    Jönsson S; Björkman A; Schultz L; Kristoffersson U
    Lakartidningen; 1997 Jan; 94(5):329-31. PubMed ID: 9053672
    [No Abstract]   [Full Text] [Related]  

  • 19. Velo-cardio-facial and partial DiGeorge phenotype in a child with interstitial deletion at 10p13--implications for cytogenetics and molecular biology.
    Lipson A; Fagan K; Colley A; Colley P; Sholler G; Issacs D; Oates RK
    Am J Med Genet; 1996 Nov; 65(4):304-8. PubMed ID: 8923940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective.
    Antshel KM; Fremont W; Kates WR
    Dev Disabil Res Rev; 2008; 14(1):43-51. PubMed ID: 18636636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.